ArticleJournal of gastrointestinal oncology2025
Lumbar centroid level subcutaneous fat volume increased performance of prognostic predictive model in digestive system cancers: a real-world cohort study.
Article in Journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Nutritional indicators play an important role in predicting the prognosis of digestive system cancers. Measures of adipose tissue distribution derived from computed tomography (CT), such as subcutaneous fat volume, are promising for assessing systemic inflammation and nutritional status. However, their integration into standardized prognostic models is still limited. This study aimed to increase the performance of the Cox regression model (Coxm) by adding the third lumbar vertebra centroid level subcutaneous fat volume (L3 CLSFV) and to assess its influence on prognostic prediction model. Methods: We constructed two Cox regression models, Coxm1 and Coxm2, using clinical features and nutritional indicators from the training cohort of patients with digestive system cancers. The Coxm1 model contained seven features, while Coxm2 incorporated an extra L3 CLSFV measured by CT. Performance was evaluated using multiple metrics in the validation cohort, including time-dependent receiver operating characteristic (timeROC), time-dependent concordance index (timeC-index), calibration curve, and Kaplan-Meier curve. The predictive accuracy of the model was further assessed using net reclassification improvement (NRI) and integrated discrimination improvement (IDI). Results: Both models had high area under the curve (AUC) (range, 0.78-0.89) and C-index values (range, 0.74-0.80). The timeROC curve showed that the inclusion of L3 CLSFV in Coxm2 did not improve the model's AUC, with similar values observed at 1-, 3-, and 5-year. Coxm2 did not improve time-dependent C-index in comparison with Coxm1. Calibration curves showed good agreement between predicted and actual survival probability in both models, with slight improvements seen in Coxm2 versus Coxm1 (Brier score, 0.166 Conclusions: The addition of the L3 CLSFV to the Cox model improved the predictive accuracy and reclassification ability. These findings suggest that incorporating extra nutritional indicators can enhance the performance of prognostic models in digestive system cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.